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ABSTRACT 
 
 
Substantial health disparities exist between African Americans and Caucasians in 
the United States. Copy number variations (CNVs) are one form of human genetic 
variations that have been linked with complex diseases and often occur at different 
frequencies among African Americans and Caucasian populations. In this study, we 
aimed to investigate whether CNVs with differential population frequencies can 
contribute to health disparities from the perspective of gene networks. We inferred 
network clusters from two different human gene/protein networks. We then evaluated 
each network cluster for the occurrences of known pathogenic genes and genes located in 
CNVs with different population frequencies, and used false discovery rates (FDRs) to 
rank network clusters. This approach let us identify five clusters enriched with known 
pathogenic genes and with genes located in CNVs with different frequencies between 
African Americans and Caucasians. These clustering patterns predict four candidate 
causal population-specific CNVs that play potential roles in health disparities. 
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 Objectives of the Study 
In this study, we aim to investigate the association of health disparities and 
genetic variations with different population frequencies, to better understand health 
disparities between African Americans and Caucasians, 
Here, we propose a novel network clustering based approach to associate 
population-specific copy number variations (CNVs) and health disparities. First, we 
obtain human gene/protein interaction networks and partition them into gene clusters. 
Second, we search pathogenic single nucleotide polymorphisms (SNPs) and population-
specific CNV loci in genome database to generate gene lists. Third, clusters are ranked 
based on results of gene enrichment tests for pathogenic genes and CNV-genes. At last, 
we investigate the biological significance of clusters that were ranked at first place. We 
will use this approach to identify CNVs that may contribute to health disparities between 
African Americans and Caucasians in diseases. 
 
1.2 Health Disparities 
 
Health disparities refer to differences in health status between people grouped by 
social or demographic factors, such as race, gender, income or geographic region. The 
differences could be in the presence of disease distribution, health outcomes, quality of 
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health care and access to health care services. In United States, health disparities between 
African Americans and other racial and ethnic populations are found in life expectancy, 
death rates, and health measures. Figure 1.1 shows the death rates of selected ethnicities 
for five causes of death in the United States. The death rates are per 100,000 population 
and age-adjusted to the 2000 census. AI, AN and PI refer to American Indian, Alaska 
Native, and Pacific Islander, respectively. As we can see, the death rates of African 
Americans are found higher than those of other populations in heart diseases, prostate 
cancer (in male), breast cancer (in female), and diabetes (National Center for Health 
Statistics 2007; National Center for Health Statistics 2013) (Figure 1.1). According to a 
recent study, eliminating health disparities would have reduced direct medical care 
expenditures by about $230 billion and indirect costs associated with illness and 
premature death by more than $1 trillion for the years 2003 to 2006 (LaVeist et al. 2011).  
 
 
Figure 1.1 Death rates of selected ethnicities for five causes of death in the United States.  
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Many factors contribute to health disparities (American Public Health 
Association). People with different socioeconomic status, such as income, education and 
occupation, will have different opinions on health practice and different access to healthy 
diet. People living in rural area and/or with low income will have trouble to obtain 
essential health care. People in different culture will have different living style, such as 
different living habit and diet, which will affect disease prevalence and health treatment 
outcome. 
In addition, human genetic variations (HGVs) play a significant role in health 
disparities (Fine et al. 2005; Ramos & Rotimi 2009). Human genes contain information 
that is required to build, regulate and maintain our bodies. HGVs are permanent changes 
in human genes and may cause alterations in an individual's phenotype, from physical 
properties to disease risk. According to “out of Africa” model, modern humans speciated 
in Africa and then migrated to other continents of the world (Stringer & Andrews 1988).  
During the migration, genetic variations occurred and kept due to random chance, natural 
selection, and other genetic mechanisms, at different frequencies from region to region 
(Tishkoff & Verrelli 2003). It is believed that genetic variations are the main reasons of 
many diseases, and thus different occurrence frequencies can lead to differences in 
disease susceptibility or resistance among various populations. Studies on associations of 
genetic variations and diseases are essential to understand disease etiology and health 
disparities, and are greatly advanced by the completion of the International HapMap 
Project (Ramos & Rotimi 2009). With the aid of modern genome sequencing techniques, 
the HapMap contains information of common human genetic variants, such as where 
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these variants occur in our DNA, and how they are distributed within and among 
different population, which can be used by researchers to link genetic variants to diseases.  
 
1.3 Genome-Wide Association Studies 
Genome-wide association studies (GWAS) are currently an effective approach to 
identify diseases-associated genetic variations (Hirschhorn & Daly 2005; Wang et al. 
2005). In GWAS, a group of diseased individuals is compared to a group of healthy 
individuals for a large number of Single Nucleotide Polymorphisms (SNPs) (Clarke et al. 
2011). The frequency of each allele is compared between two groups and a statistical test 
is performed with a null hypothesis that no association exists between disease and the 
SNP. Usually tests of millions of SNPs are carried out, which requires multiple 
hypothesis testing procedures to control false positives (Dudbridge & Gusnanto 2008). 
Although GWAS have revealed many disease-associated SNPs, only a few of them are 
associated with moderate or large increase in disease risk, and some well-known genetic 
risk factors have been missed (Williams et al. 2007). One possible reason is that GWAS 
focus only on individual genetic variations and do not address complex gene interactions 
(Moore & Williams 2009). Another possible reason is that the current statistical analysis 
is “unbiased”, since it ignores available knowledge of disease pathobiology (Moore et al. 
2010).  
Several approaches tried to incorporate GWAS results with known biological 
knowledge. One of them is called Gene Set Analysis (GSA) (Cantor et al. 2010; Lehne et 
al. 2011; Wang et al. 2007), which associates variations in an entire set of genes with a 
phenotype. A gene set is defined as a set of genes that are involved in common biological 
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processes or pathways, or as a set of interacting proteins identified from protein-protein 
interaction networks (Lehne et al. 2011). In GSA, enrichment tests are performed by 
comparing the frequency of significantly associated SNPs in a particular set of genes with 
that among all other genes not in the set. Gene sets containing significantly more 
associated SNPs will have closer association with the corresponding phenotypes. The 
advantage of GSA is that it detects associations of the phenotype with a gene set, not 
individual SNPs. Therefore it does not ignore SNPs that have low p-values but still 
contribute to phenotypes, and it reduces the number of statistical tests and requires less 
stringent multiple testing correction (Lehne et al. 2011). 
 
1.4 Copy Number Variations 
Unlike SNPs, which affect only one single nucleotide base, copy number 
variations (CNVs) are duplications or deletions of relatively large genomic segments that 
can contain one or more genes (Feuk et al. 2006; Freeman et al. 2006). The widespread 
presence of CNVs in normal individuals was first reported in 2004 (Iafrate et al. 2004; 
Sebat et al. 2004). And to date, over 100,000 non-overlapping human CNVs have been 
identified, with the size varying from 50 base pair to more than one million bases pairs, 
and they cover about 70% of the whole genome (MacDonald et al. 2014). 
In early genetic association studies, CNVs have been associated with various 
complex diseases (Feuk et al. 2006; Ionita-Laza et al. 2009). Updates on CNVs’ roles in 
some diseases, such as psychoses (Lee et al. 2012), autism (Wang et al. 2013), 
autoimmunity (Olsson & Holmdahl 2012) and schizophrenia (Hosak et al. 2012), have 
been reviewed recently. Computational tools and methods have been developed to help 
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address the potential roles of CNVs in human diseases. The CNVannotator was 
developed to provide considerable capabilities for researchers to annotate specific CNVs 
in a reliable and efficient manner (Zhao & Zhao 2013). The NETBAG+ algorithm was 
developed to search for strongly cohesive gene clusters affected by CNVs, using a 
likelihood network constructed based on a combination of various functional descriptors. 
(Gilman et al. 2012). Recently, it is reported that CNVs can occur at different frequencies 
between African Americans and Caucasians (McElroy et al. 2009), and naturally the 
question about the potential roles of CNVs in health disparity is raised.  
 
1.5 Protein-Protein Interaction Networks 
Protein-protein interactions (PPIs) play diverse roles in biology. It is observed that 
proteins seldom carry out their function in isolation, and usually proteins involved in the 
same cellular processes interact with each other (von Mering et al. 2002). Advanced 
high-throughput technologies, such as yeast-two-hybrid screening, mass spectrometry, 
and protein microarray chip technologies, have generated huge data sets of protein-
protein interactions (von Mering et al. 2002).  
Several databases have been constructed as repositories for experimentally 
discovered protein interactions (Mathivanan et al. 2006). PPIs are incorporated into PPI 
databases through curation from the literatures by biologists, or through direct deposit by 
the investigators before their publication. For example, Human Protein Reference 
Database (HPRD) is a joint project between the Institute of Bioinformatics in Bangalore, 
India and the Pandey lab at Johns Hopkins University in Baltimore, USA. HPRD 
contains annotations related to human proteins based on experimental evidence from the 
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literature (Mishra et al. 2006; Peri et al. 2004; Prasad et al. 2009). HPRD includes not 
only PPIs, but also interactions between proteins and other small molecules, as well as 
information about post-translational modifications, subcellular localization, protein 
domain architecture, tissue expression and association with human diseases. PPIs in 
HPRD are usually direct physical interactions. Pairwise interactions are often represented 
by undirected links in a graph model of network. Some databases contain indirect genetic 
or regulatory interactions, and some contain directional interactions such as those in 
phosphorylation, metabolic, signaling and regulatory networks. In one study, various 
interaction data have been put together to construct a unified global network named 
MultiNet (Khurana et al. 2013).  
Protein-protein interaction (PPI) data can be represented in the form of networks, 
in which nodes are proteins and edges are interactions. The protein-protein interaction 
network (PPIN) can help understand the basic scheme of cell functions by correlating the 
components of the network with their cellular functions, which can be done by clustering 
processes (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). In PPIN, a cluster is a 
set of genes that share a large number of interactions, and the clustering process is to 
group genes into clusters which contain more interactions among genes in the same 
cluster than in different clusters. Clustering process can identify both protein complexes 
and functional modules (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). Protein 
complexes are groups of proteins that bind to each other at the same time and place, 
while functional modules consist of proteins that participate in the same cellular process 
through interactions between themselves at a different time and place. Usually the PPINs 
do not contain information about when and where proteins interacts, therefore protein 
8 
 
complexes and functional modules are not treated differently in clustering processes. The 
results of clustering process of PPINs can help to infer the principal function of each 
cluster from the functions of its members, and suggest possible functions of cluster 
members based on the functions of other members.  
Many distance-based or graph-based clustering algorithms were developed to 
cluster PPINs (Lin et al. 2007; Pizzuti et al. 2012; Wang et al. 2010). The Markov 
Clustering (MCL) algorithm is a fast, scalable, and unsupervised clustering algorithm, 
which simulates stochastic flows in graphs (van Dongen 2000). The algorithm simulates 
random flows within a graph by alternation of two operations called expansion and 
inflation. In expansion, the flow moves within the same dense regions or out to other 
dense regions. The inflation operation strengthens the flow within the dense regions and 
weakens the flow out of the dense regions. The expansion and inflation steps are repeated 
until a steady state is reached. A recent study compared MCL with other three clustering 
algorithms, restricted neighborhood search clustering (RNSC), super paramagnetic 
clustering (SPC) and molecular complex detection (MCODE), on six PPINs to detect 
previously annotated gene clusters (Brohee & van Helden 2006). The conclusion was that 
MCL algorithm outperformed the other algorithms in the extraction of complexes from 
interaction networks. 
 
1.6 Network-Based Analysis 
Gene/Protein interaction networks combined with GWAS data can help 
understand complex biological activities and cellular mechanisms of complex diseases 
(Barabasi et al. 2011; Halldorsson & Sharan 2013; Sharan et al. 2007; Vidal et al. 2011; 
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Wang et al. 2011). This is based on the assumption of “guilt by association”, which 
means that genes associated with the same or related functions or diseases tend to interact 
with each other and cluster together with high connectivity in networks (Altshuler et al. 
2000; Oliver 2000).  
One example of using PPIN to identify disease-associated genes was reported in a 
study of incident Coronary Heart Disease (CHD) (Jensen et al. 2011). In this study, an 
experiment-derived PPI database InWeb was used to produce unbiased protein complexes 
and corresponding gene sets, which were then ranked based on results of enrichment tests 
of CHD-associated genes. In the identified gene set, five out of 19 genes were involved in 
abnormal cardiovascular system physiological features, and pathways related to blood 
pressure regulation were significantly enriched. 
Another methodology that utilizes the PPINs to discover disease associated 
clusters is called the pathway and network oriented GWAS analysis (PANOGA), which 
combines GWAS data with current knowledge of biochemical pathways, PPINs, and 
functional and genetic information of selected SNPs (Bakir-Gungor & Sezerman 2011). 
In their study, genes related to significant SNPs from GWAS data were identified and 
were assigned with functional attributes, which were used in the process of identifying 
clusters associated with the disease. Then, genes in one identified cluster were tested 
whether they are part of important pathways. The application of this methodology on 
Rheumatoid Arthritis (RA) dataset identified new RA-associated pathways, in addition to 
pathways previously identified by GWAS analysis. The newly identified pathways were 
found to include many genes that are known to be used as drug targets for the treatment 
of RA. Moreover, new genes have been identified to be associated with RA. 
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Protein interactions could provide important clues to help illustrate SNP’s 
functional association (Huang et al. 2010). Protein interaction network was combined 
with other traditional hybrid features, such as sequence, structure and pathway properties, 
and it was used to establish predictors using hundreds of those features. These predictors 
can correctly identify around 80% of known disease-associated SNPs and is valuable to 
predict undiscovered disease-associated SNPs. 
In another approach, a genome-scale functional gene network, named HumanNet, 
was constructed by incorporating gene expression, protein interaction, sequence and other 
genomic data to prioritize candidate disease genes, which can facilitate both seed gene-
based and GWAS-based disease association studies (Lee et al. 2011). In seed gene-based 
approach, gene connections in the network were assigned with weights, calculated by 
using label propagation algorithms based on their distance to the seed genes. Genes 
connected to seed genes with larger weights were be considered as more likely to be 
associated with target diseases. Although for GWAS data there are no definite seed genes, 
this approach can still boost the power of association analysis by using a different ranking 
score (Lee et al. 2011). In the analysis of Crohn’s disease and type 2 diabetes, the 
HumanNet not only boosted the identification of correct associations, but organized the 
associated genes into processes, which arouse attentions to genes that were not 
significantly identified in GWAS. 
 
1.7 Contributions of the Study 
Although genetic factors play a crucial role in health disparities, only a few 
association studies have been reported in common complex diseases, such as breast 
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cancer (Long et al. 2013), prostate cancer (Bensen et al. 2014; Bensen et al. 2013; Xu et 
al. 2011), type 2 diabetes (Ng et al. 2014) and vascular diseases (Wei et al. 2011). In 
order to better understand health disparities between African Americans and Caucasians, 
we aim to investigate the association of health disparities and genetic variations with 
different population frequencies.  
Here, we propose a novel network clustering based approach on CNVs for health 
disparities. First, we choose to focus on CNVs. Although CNVs are one important type of 
genetic variations, and can occur at different frequencies among African Americans and 
Caucasians, no association studies have been reported so far to our best knowledge. 
Therefore, this work is the first study on association of CNVs and health disparities. 
Second, our approach is on gene level, and pathogenic SNPs and population specific 
CNV loci are mapped to corresponding gene names. Current GWAS on health disparities 
still focused on individual SNPs, but we choose to focus on genes, because only a small 
fraction of the genetic heredity of most diseases can be explained by the SNPs, and a 
gene-based approach can allow us using the information encoded by protein interaction 
networks (Lee et al. 2011). Third, association analysis in our approach uses gene clusters 
inferred from gene networks, which is based on the rationale that interacting genes often 
have the same functions or participate in the same biological processes. In addition, 
unlike common Gene Set Analysis (GSA) studies that compares significantly associated 
SNPs (Cantor et al. 2010; Lehne et al. 2011; Wang et al. 2007), our novel approach 
compares the frequency of pathogenic genes or population specific CNV related genes 
between clusters to evaluated the relationship between clusters and diseases or CNVs.  
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CHAPTER II 
 
MATERIALS AND METHODS 
 
 
This chapter introduces materials (gene/protein networks and gene sets) we 
collected and prepared for this study, and methods we used in clustering process, cluster 
analyses and biological significance analysis. 
Our overall work flow is shown in Figure 2.1. To identify potential CNVs 
associated with health disparities, our basic idea is to identify gene clusters that are 
enriched with both pathogenic genes and genes located in population-specific CNVs. 
Health disparities in diseases associated with identified clusters could be considered as 
results of the occurrence of corresponding CNVs. Specifically, we first obtained two 
human gene/protein networks and partitioned them into gene clusters. We then identify 
disease-associated genes and genes located in population-specific CNVs in those clusters. 
Statistical tests were performed on each cluster to estimate its significances of containing 
pathogenic genes and genes in population-specific CNVs. Finally, we ranked gene 
clusters based on false discovery rates (FDRs). Top-ranked clusters were enriched both 
for pathogenic genes and for genes in CNVs with differential frequencies between 
African-Americans and Caucasians. These clusters were then searched for enriched Gene 
Ontology (GO) terms and related disease phenotypes to identify corresponding biological 
significance. 
 
  
Figure 2.1 Overview of our approach to identify CNVs associated with health disparities
2.1 Network Clustering 
We obtained two human 
Reference Database (HPRD) 
another from MultiNet (Khurana et al. 2013
HPRDNet) is one of the largest human gene/protein interaction networks, and 
only physical protein-protein interactions (PPIs)
including PPI, phosphorylation, 
These two networks share 8468 genes (89.6% of HPRDNet and 58.6% of MultiNet)
only 8769 interactions (23.8% of HPRDNet and 8% of MultiNet). 
were both partitioned into gene clusters using the M
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Dongen 2000). MCL (version10-201) was installed and run in an Ubuntu 11.10 system. 
The following command was used to run clustering:           
mcl <network> --abc -I <I value> --force-connected=y -o <result>                                     
Option <network> refers to the input file that contains the gene/protein interaction 
network. In the input file, each line contains a pair of gene names, separated by a tab 
space, which represent a gene-gene interaction. Option <I value> refers to the inflation 
parameter I, which was from 1.1 to 2.0 with a step of 0.1. Option <result> refers to the 
output file to which the clustering results will be saved. In the output file, each line 
contains a set of gene names separated by a tab space, which are member of a cluster. 
 
2.2 Gene Mapping of CNVs and SNPs 
Two sets of genes were used in this study: genes located in population-specific 
CNVs and pathogenic genes. Currently, there are no ready-made sources containing 
information of these genes. However, coordinates of disease-associated SNPs and 
population-specific CNVs were available and were searched in the UCSC Genome 
Database (Karolchik et al. 2014) through its MySQL API to obtain the corresponding 
gene name sets. All works were done using codes in Java. The following Java statements 
were used to establish the connection to UCSC Genome Database MySQL interface: 
 // setup connection to UCSC Genome Database 
String username = "genome"; 
 String password = ""; 
 String url = "jdbc:mysql://genome-mysql.cse.ucsc.edu/hg19"; 
 Class.forName("com.mysql.jdbc.Driver"); 
 Connection con = DriverManager.getConnection(url, username, 
password); 
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CNV coordinates were obtained from a CNV map in African Americans and 
Caucasians (McElroy et al. 2009). There are three types of CNVs in this map: (1) CNVs 
only occur in African Americans, (2) CNVs only occur in Caucasians, and (3) CNVs 
occurred in both African Americans and Caucasians. To simplify the analysis, we further 
partitioned the last type: CNVs that occurred more than 50% in African Americans or in 
Caucasians were combined with the first and second types of CNVs, respectively. This 
repartition resulted in two modified CNV sets with differential population frequencies. 
The coordinates of these CNVs were then searched in the UCSC Genome Database 
through its MySQL API to obtain the corresponding gene sets. The SQL statements were 
formed in Java codes (APPENDIX A) and submitted, in which begin, end, and chrom 
refer to the starting positions, ending positions and chromosomes of the CNVs, 
respectively: 
// search related genes of CNVs 
select distinct X.geneSymbol, G.chrom, G.txStart, G.txEnd 
from knownGene as G, kgXref as X 
where ((G.txStart>begin AND G.txEND<end or  
(G.txStart>begin AND G.txStart<end or  
(G.txEND>begin AND G.txEND<end or  
  (G.txStart<begin AND G.txEnd>end AND 
   X.kgId = G.name AND G.chrom = chrom); 
 
For simplicity, CNVs that occur more frequently in African Americans were called 
African-American CNVs or CNV_AA; CNVs that occur more frequently in Caucasians 
were called Caucasian CNVs or CNV_CA. 
Disease-associated SNPs were retrieved from a file, OmimVarLocusIdSNP.bcp, 
obtained from the FTP site of Single Nucleotide Polymorphism Database (dbSNP) 
(Sherry et al. 2001). Coordinates of these SNPs were then queried against the MySQL 
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API of the UCSC Genome Database to identify genes in which those SNPs are located. 
The following SQL statements were composed in Java codes (see APPENDIX A) and 
submitted, in which SNP refers to the RSid of the SNPs: 
//search related genes of SNPs. 
select distinct S.name, X.geneSymbol 
from snp138 as S, knownGene as G, kgXref as X 
where S.name = SNP AND  
      X.kgId = G.name AND S.chrom = G.chrom AND 
      G.txStart <= S.chromStart AND G.txEnd >= S.chromEnd; 
 
This identified gene set was termed as pathogenic genes.  
 
2.3 Cluster Analyses 
Clusters were obtained from both HPRDNet and MultiNet using MCL with a 
range of ten inflation parameters. For each cluster, contingency tables were constructed 
using the numbers of pathogenic genes and population-specific CNV-related genes.  
Table 2.1 is for pathogenic significance test, and Table 2.2 is for tests of enrichment 
significance of CNVrelated genes (CNV_AA or CNV_CA genes). Q and q are the 
number of pathogenic genes in the whole networks and that in current cluster, 
respectively. N and m are the number of genes in whole networks and that in current 
cluster, respectively. S and s are the number of CNV_AA or CNV_CA genes in the 
whole networks and that in current cluster, respectively. 
In statistics, a contingency table is a type of table that displays the frequency 
distribution of multiple variables, usually in a two by two format. The significance of the 
difference between the two proportions (derived based on observed frequencies) can be 
evaluated by various statistical tests, such as Pearson's chi-squared test and Fisher's exact 
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test. If the proportions in the different columns are significantly different between rows 
(or vice versa), we say that there is a contingency between the two variables. In our case, 
we want to know whether a cluster contains more pathogenic genes or population-
specific CNV-related genes than all of the other clusters. If it does, we say this cluster is 
enriched with such genes and thus has stronger connections to diseases or is more likely 
to be affected by population-specific CNVs. If a cluster is found to be significant in both 
enrichment tests, it will be of most interest to us. 
 
Table 2.1 
 
Contingency table for Fisher’s exact test on pathogenic genes 
 
 Pathogenic Genes Non-pathogenic Genes Total 
Genes in this cluster q m-q m 
Genes in other clusters Q-q N-Q-m+q N-m 
Total Q N-Q N 
 
 
 
Table 2.2 
 
Contingency table for Fisher’s exact test on CNV genes 
 
 CNV Genes Non-CNV Genes Total 
Genes in this cluster s m-s m 
Genes in other clusters S-s N-S-m+s N-m 
Total S N-S N 
 
 
 
In this study, right-tailed Fisher’s exact tests were applied to these contingency 
tables to calculate enrichment significance of pathogenic genes, CNV_AA or CNV_CA 
genes, respectively. Fisher's exact test is a statistical test used in the analysis of 
18 
 
contingency tables. It is valid for all sample sizes, but in practice it is employed mostly 
when sample sizes are small, which is the main reason it is chosen in for our analyses. 
Using Table 2.1 as an example, the null hypothesis H0 is that the proportion of 
pathogenic genes in one cluster less than or equals to that in all other clusters, and the 
alternative hypothesis H1 indicates that this pathogenic occurrence in this cluster is more 
than random expectation: 
 : 



 	 

 	 
 
 
 : 



 	 

 	 
 
 
in which Q and q are the number of pathogenic genes in the whole networks and that in 
current cluster, respectively, and N and m are the number of genes in whole networks and 
that in current cluster, respectively. In other words, if the null hypothesis is true, we 
would have  
 



×  
The question we ask is: what is the probability that the observed q value is larger than the 
expected value in the null hypothesis? The right-tailed Fisher’s exact test will give the 
answer: if the p-value is small (common cutoff values are 0.001, 0.01, 0.05, or 0.10), we 
can say that in this cluster pathogenic genes were significantly enriched. The smaller the 
p-values, the more significant the enrichment is. The right-tailed Fisher’s exact tests were 
performed in the R statistical environment (R Development Core Team 2013), with the 
following R statements composed in Java codes (see APPENDIX B) and submitted to the 
R engine: 
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 // pathogenic gene enrichment tests. 
 cluster = c(q, m-q); 
 other = c(Q-q, N-Q-m+q); 
 tb = rbind(cluster, other); 
 fisher.test(tb, alternative="greater")$p.value; 
 
 // population-specific CNV-related gene enrichment tests. 
 cluster = c(s, m-s); 
 other = c(S-s, N-S-m+s); 
 tb = rbind(cluster, other); 
 fisher.test(tb, alternative="greater")$p.value; 
 
The right-tailed Fisher’s exact tests were performed to each cluster in each 
clustering results, which led to the multiple comparisons problem. The multiple 
comparisons problem, or multiple testing problem, occurs when a set of statistical tests 
are performed simultaneously (Miller 1981), in which the null hypothesis are more likely 
to be incorrectly rejected based on individual tests when all tests were considered as a 
whole. The False discovery rate (FDR) control is a statistical method to correct for 
multiple comparisons. In a list of tests, FDR procedures are designed to control the 
proportion of incorrectly rejected null hypotheses, i.e. “false discoveries” (Benjamini & 
Hochberg 1995). There are many statistical procedures that use p-values to estimate or 
control the FDR, such as Benjamini-Hochberg procedure (Benjamini & Hochberg 1995) 
and Q-value procedure (Storey et al. 2004). However, most of them assume that p-values 
are continuously distributed and based on two-sided tests. Therefore, it is difficult to 
reliably estimate the FDR when the p-values are discrete or based on one-sided tests. 
Since p-values in our study are discrete and based on one-sided tests, a proper FDR 
calculation procedure needs to be carefully chosen. The Robust FDR Routine does not 
rely on the assumptions that tests are two-sided or yield continuously p-values, and was 
shown to have excellent performance in a series of data (Pounds & Cheng 2006). Based 
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on obtained p-values from the right-tailed Fisher’s exact tests, we calculated FDRs using 
the Robust FDR Routine in the R statistical environment. The following R statements 
were composed in Java codes (see APPENDIX C) and submitted to the R engine: 
// Run robust FDR routine. 
// p is the vector of all sorted p-values. 
robust.fdr(p, discrete=T, use8=F)$fdr"; 
 
  Ranking were applied to clusters with p-value<0.10 and FDR<0.20 in both 
enrichment tests for pathogenic genes and population-preferred CNVs genes. Assuming 
both tests are independent, the FDR values were multiplied and the products were used to 
rank the network clusters.  
The same cluster analysis procedure was applied to each clustering results with 
different MCL inflation parameters. For clarity, we focused our biological significance 
analyses on clusters that were consistently ranked at the first place with different MCL 
inflation parameter values.   
 
2.4 Biological Significance Analyses 
To understand the biological significance of the clusters, their corresponding 
Gene Ontology (GO) terms were analyzed. Gene ontology is a project to unify the 
representation of gene and gene product attributes (Gene Ontology Consortium 2008). 
More specifically, the project aims to develop and maintain the vocabulary of gene and 
gene product attributes, annotate genes and gene products, and provide tools for data 
access and functional interpretation. GO terms describe properties of genes and their 
products and are grouped into three domains: cellular component (where they locate), 
molecular function (what they do at the molecular level), and biological process (which 
21 
 
molecular events they participate). One of the main uses of the GO terms is to perform 
enrichment analysis on gene sets by comparing one target gene set to the background 
gene set. If a GO term appears more often in the target gene set than in the background 
gene set, it is said to be enriched in this gene set, or this gene set is highly related to this 
GO term, which could help to understand the underlying biological relevance. 
In this study, biological relevance of selected network clusters were analyzed by 
the Gene Ontology enrichment analysis and visualization tool, or GOrilla (Eden et al. 
2009) to search for enriched GO terms. In GOrilla search, genes in the selected clusters 
were target genes, and all other genes in the network were treated as background genes.  
To investigate the possible links of population-specific CNVs to heath disparities, we 
first identified significantly enriched GO terms that are associated with CNV_AA or 
CNV_CA genes. We then focused on the pathogenic genes associated with the enriched 
GO terms, and examined their related disease phenotypes in OMIM database (Online 
Mendelian Inheritance in Man 2014). These disease phenotypes were searched for 
reported health disparities between African American and Caucasian populations. 
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CHAPTER III 
 
RESULTS AND DISCUSSION 
 
 
This chapter shows our results in network clustering, gene mapping and cluster 
analyses, and discusses the plausible links of population-specific CNVs in the identified 
network clusters to health disparities. 
 
3.1 Network Clustering Results 
 
Two gene/protein interaction networks were chosen in this study: HPRDNet and 
MultiNet. For HPRDNet, three types of interactions were removed before clustering 
process: 1) interaction between same gene; 2) interaction involving unknown genes; 3) 
and interactions with ambiguous genes. For MultiNet, all interactions were submitted to 
clustering process. Clusters were inferred using MCL with ten different inflation values. 
Descriptive statistics of the two networks and their clustering results are summarized in 
Table 3.1. When inflation parameter I was increased, the cluster sizes decreased and the 
cluster numbers increased. This is because higher I value increases the granularity or 
tightness of clusters. The “--force-connected=” option is also proven to have an effect on 
clustering results for both networks. When this option was set to “N”, we identified 
several uninformative clusters with some genes do not connect to any other genes in the 
same cluster.  
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Table 3.1 
 
Summary of biological networks 
 
Network Inflation Value 
Total 
Clusters 
Cluster Sizes 
Maximum Minimum Median Mean 
HPRDNet: 
  9451 genes 
  36880 interactions 
1.1 111 9203 2 2 85 
1.2 128 9025 1 2 74 
1.3 363 3454 1 3 26 
1.4 660 432 1 5 14 
1.5 1036 260 1 4 9 
1.6 1401 192 1 3 7 
1.7 1704 152 1 3 6 
1.8 1990 146 1 3 5 
1.9 2222 119 1 3 4 
2.0 2447 90 1 3 4 
MultiNet: 
  14445 genes 
  109598 interactions 
1.1 21 14399 2 2 450 
1.2 22 14394 2 2 430 
1.3 43 13614 1 2 220 
1.4 226 5560 1 3 42 
1.5 600 3524 1 2 16 
1.6 923 2402 1 2 10 
1.7 1387 1589 1 2 7 
1.8 1660 1215 1 2 6 
1.9 1887 996 1 2 5 
2.0 2116 804 1 2 4 
 
 
 
 
3.2 Gene Mapping Results 
Chromosome coordinates of pathogenic SNPs and population-specific CNVs 
were searched in the UCSC Genome Database. Totally 2810 pathogenic genes, 194 
CNV_AA genes and 258 CNV_CA genes were obtained. Since this study focuses on 
network-derived gene clusters, only genes that are listed in HPRDNet or MultiNet were 
kept. Details of gene mapping results are shown in Table 3.2. 
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Table 3.2 
 
Results of gene mapping of SNPs and CNV coordinates 
 
 Pathogenic Genes CNV_AA CNV_CA 
Total 2810 194 258 
in HPRDNet 1791 48 62 
in MultiNet 2143 64 97 
 
 
 
3.3 Cluster Analysis Results 
We performed cluster analyses on each of the ten clustering results for both 
HPRDNet and MultiNet. Ranking were applied only to clusters with p-value<0.10 and 
FDR<0.20 in both enrichment tests for pathogenic genes and those for population-
preferred CNVs genes. The products of FDRs of both enrichment tests were used to rank 
the network clusters.  
The ranking results are listed in Table 3.3 and Table 3.4. The value of inflation 
parameter I used in clustering process is from 1.1 to 2.0, increased by 0.1. Cluster NO is 
the serial number of a cluster. CNV_AA and CNV_CA are CNV-related genes. Cluster 
Names are names of clusters selected for biological significance analyses. p_CNV and 
FDR_CNV, and p_OMIM and FDR_OMIM are p-values and FDR values from 
enrichment tests for CNV-related genes and pathogenic genes, respectively. FDR product 
is the multiplication result of FDR_CNV and FDR_OMIM and is used for ranking.  
We focused on clusters that were consistently ranked at the first place with 
different MCL inflation parameter values for further biological significance analyses. It is 
worth to mention that clusters containing gene CYP2E1 were filtered out, although in 
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HPRDNet these clusters have been ranked three times at first place in cluster ranking for 
CNV_AA gene enrichment tests, and three times at first place for CNV_CA gene 
enrichment tests (Table 3.3). This is because gene CYP2E1 is affected by multiple CNVs 
and these CNVs have different population preferences. CYP2E1’s location was compared 
with those CNVs’ loci. It is found that CYP2E1 is located in the overlapped region 
among those CNVs, which means it may not have CNV-caused population-preferred 
variations, and may not contribute to health disparities. Therefore, clusters containing 
gene CYP2E1 were not included in the following analysis, and the corresponding clusters 
ranked at second place were selected instead. 
Details of selected clusters are listed in Table 3.5, and their graph representations 
are shown in Figure 3.1. In Figure 3.1, each rounded rectangle represents a gene and each 
gray line represents a gene-gene interaction. Black rounded rectangles represent non-
pathogenic genes and orange rounded rectangles represent pathogenic genes. Genes 
labeled with red or blue ovals are located in African American CNVs or in Caucasian 
CNVs. Genes with Green lines share the same GO terms. In each cluster, different line 
types represent the enrichment of different GO terms. Line types shown in different 
clusters refer to the enrichment of different GO terms. The CNV_AA or CNV_CA genes 
in the selected clusters and the details of their corresponding CNVs are listed in Table 3.6. 
In Table 3.6, Chr represents chromosomes. CNV Regions are regions of CNVs identified 
in more than a single individual. All CNVs listed have a type of Duplication, referring to 
one copy increase. CNV Regions and Types are from the CNV map (McElroy et al. 
2009). CNV Occurrence describes in CNVs occurrence in African American and 
Caucasian populations.  
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Table 3.3 
 
Top-ranked clusters from HPRDNet 
 
I Cluster No 
Cluster 
Name CNV_AA CNV_CA OMIM Size p_CNV FDR_CNV p_OMIM FDR_OMIM 
FDR 
product 
1.1 -  - - - - - - - - - 
1.2 -  - - - - - - - - - 
1.3 -  - - - - - - - - - 
1.4 175 AA1 HSPB1 - 8 11 0.0534 0.1548 1.56E-4 3.78E-6 5.85E-07 
1.5 190 AA1 HSPB1 - 8 11 0.0534 0.1032 1.56E-4 1.45E-5 1.50E-06 
 
187  CYP2E1 - 5 11 0.0534 0.1032 0.0408 0.1772 1.83E-02 
 
429 CA1 - ATP2A1 4 5 0.0324 0.1094 0.0055 1.80E-5 1.97E-06 
 
271  - SLC4A4 5 8 0.0513 0.1241 0.0082 4.01E-4 4.98E-05 
 
257  - CRX 5 9 0.0575 0.1260 0.0155 0.0155 1.95E-03 
1.6 162 AA2 HSPB1 - 8 12 0.0581 0.0964 3.91E-4 4.08E-5 3.93E-06 
 
181  CYP2E1 - 5 11 0.0534 0.0936 0.0408 0.1796 1.68E-02 
 
470 CA1 - ATP2A1 4 5 0.0324 0.0896 0.0055 0.0369 3.31E-03 
 
392  - SLC4A4 4 6 0.0387 0.1007 0.0139 0.1238 1.25E-02 
1.7 142 AA2 HSPB1 - 8 12 0.0581 0.0842 3.91E-4 0.0454 3.82E-03 
 
509 CA1 - ATP2A1 4 5 0.0324 0.0690 0.0055 0.1989 1.37E-02 
1.8 444  CYP2E1 - 5 6 0.0295 0.0628 0.0012 0.1231 7.73E-03 
 
109 AA3 HSPB1 - 8 13 0.0628 0.0889 8.48E-4 0.1010 8.98E-03 
 
444  - CYP2E1 5 6 0.0387 0.0781 0.0012 0.1231 9.61E-03 
 
516 CA1 - ATP2A1 4 5 0.0324 0.0756 0.0055 0.1910 1.44E-02 
1.9 430  CYP2E1 - 5 6 0.0295 0.0246 0.0012 0.1171 2.88E-03 
 
430  - CYP2E1 5 6 0.0387 0.0684 0.0012 0.1171 8.01E-03 
2.0 412  CYP2E1 - 5 6 0.0295 0.0241 0.0012 0.1594 3.84E-03 
 
412   CYP2E1 5 6 0.0387 0.0470 0.0012 0.1594 7.49E-03 
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Table 3.4 
 
Top-ranked clusters from MultiNet 
 
I Cluster No. 
Cluster 
Name CNV_AA CNV_CA OMIM Size p_CNV FDR_CNV p_OMIM FDR_OMIM 
FDR 
product 
1.1 -  - - - - - - - - - 
1.2 -  - - - - - - - - - 
1.3 -  - - - - - - - - - 
1.4 30  ANXA8, IGHG1 - 12 46 0.0176 0.1588 0.0326 0.1745 2.77E-02 
 
85 CA1 - ATP2A1 4 5 0.0331 0.1501 0.0021 0.0289 4.34E-03 
1.5 174 AA4 HSPB1 - 5 5 0.0220 0.0979 7.16E-5 0.0023 2.25E-04 
 
188 CA1 - ATP2A1 4 5 0.0331 0.1237 0.0021 0.0345 4.27E-03 
1.6 258 AA4 HSPB1 - 5 5 0.0220 0.0743 7.16E-5 0.0035 2.60E-04 
 
277 CA1 - ATP2A1 4 5 0.0331 0.1708 0.0021 0.0384 6.56E-03 
1.7 320 AA4 HSPB1 - 5 5 0.0220 0.0838 7.16E-5 0.0057 4.78E-04 
 
351 CA1 - ATP2A1 4 5 0.0331 0.1814 0.0021 0.0467 8.47E-03 
1.8 377 AA4 HSPB1 - 5 5 0.0220 0.0809 7.16E-5 0.0067 5.42E-04 
 
412 CA1 - ATP2A1 4 5 0.0331 0.1347 0.0021 0.0509 6.86E-03 
 
248  - CLN3 4 7 0.0461 0.1459 0.0116 0.1625 2.37E-02 
1.9 410 AA4 HSPB1 - 5 5 0.0220 0.0747 7.16E-5 0.0078 5.83E-04 
 
443 CA1 - ATP2A1 4 5 0.0331 0.1159 0.0021 0.0663 7.68E-03 
 
316  - CLN3 4 6 0.0396 0.1190 0.0056 0.1118 1.33E-02 
2.0 142  ECHS1 - 8 12 0.0519 0.1196 6.55E-5 0.0096 1.15E-03 
 
479 CA1 - ATP2A1 4 5 0.0331 0.0988 0.0021 0.0728 7.19E-03 
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Table 3.5 
 
Cluster analysis results for HPRDNet and MultiNet 
 
Network Cluster Name CNV_AA CNV_CA 
Pathogenic  
gene number 
Cluster  
Size 
HPRDNet AA1 HSPB1 - 8 11 
 
AA2 HSPB1 - 8 12 
 
AA3 HSPB1 - 8 13 
 
CA1 - ATP2A1 4 5 
MultiNet AA4 HSPB1 - 5 5 
 
CA1 - ATP2A1 4 5 
 
 
 
 
 
Figure 3.1 Graph representations of selected clusters for biological significance analysis 
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Table 3.6 
 
Selected genes with potential roles in health disparities and their located CNVs 
 
Gene Chr Gene Coordinates CNV Region CNV Type CNV Occurrence  
HSPB1 7 75,931,861-75,933,614 75,867,431-76,481,102 Duplication Only in African American 
   75,929,740-76,481,102 Duplication Only in African American 
   75,929,740-76,568,388 Duplication higher in African American than in Caucasian 
ATP2A1 16 28,889,726-28,915,830 28,306,730-28,936,772 Duplication Only in Caucasian 
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3.3.1 Clusters enriched with genes located in African American CNVs 
 
We found four similar clusters, (AA1, AA2, and AA3 in HPRDNet and AA4 in 
MultiNet), that are enriched both for pathogenic genes and for genes located in African-
American CNVs (Table 3.5). In HPRDNet, cluster AA1, AA2 and AA3 together were 
ranked at first place five times; and cluster AA4 were ranked at first place five times in 
Multinet (Table 3.4). Cluster AA1 contains 11 genes, within which eight are pathogenic 
genes (Figure 3.1A). Cluster AA2 and AA3 contain one and two more genes than cluster 
AA1, respectively (Figure 3.2). In MultiNet, cluster AA4 contains five genes and can be 
considered as a sub-cluster of cluster AA1, AA2 and AA3 (Figure 3.1B). All four clusters 
contain gene HSPB1 (Table 3.5), which is mainly duplicated in African Americans 
(Table 3.6). Since cluster AA1, AA2 and AA3 were selected from the same network and 
are highly similar to each other, only cluster AA1 and AA4 were studied in biological 
significance analyses.  
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Figure 3.2 Graph representations of cluster AA1, AA2 and AA3. 
 
 
 
3.3.2 Clusters enriched with genes located in Caucasian CNVs 
 
In both HPRDNet and MultiNet, the same cluster, named as CA1, was identified 
to be enriched with both pathogenic genes and genes located in Caucasian CNVs (Table 
3.5). Cluster CA1 was ranked at first place four times in HPRDNet (Table 3.3) and seven 
times in MultiNet (Table 3.4). This cluster contains five genes, and four of them are 
associated with diseases (Figure 3.1C). Cluster CA1 contains gene ATP2A1 which is 
duplicated only in Caucasians (Table 3.6). 
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3.4 Plausible Links of population-specific CNVs in the identified Network Clusters      
      to Health Disparities 
To investigate the possible links of population-specific CNVs to heath disparities, 
we first identified significantly enriched GO terms that are associated with CNV_AA or 
CNV_CA genes in the identified network clusters. We then focus on the pathogenic 
genes with the enriched GO terms, and examined their associated disease phenotypes in 
OMIM database. The results of GO term enrichment analysis are listed in Table 3.7, and 
the associated diseases are listed in Table 3.8.  
 
Table 3.7  
 
Enriched GO terms with CNV-genes in the identified network clusters 
 
Clusters Involved Genes GO Domain GO ID GO term 
AA1 HSPB1, CRYAA, 
CRYAB,  
CRYBB2, 
CRYBA1, 
CRYBA2 
Molecular 
Function 
GO:0042802 Identical protein binding 
AA4 HSPB1, CRYAA, 
CRYAB 
Biological 
Process 
GO:0043086 negative regulation of 
catalytic activity 
   GO:0043066 negative regulation of 
apoptotic process 
   GO:0043069 negative regulation of 
programmed cell death 
 HSPB1, CRYAA,  
CRYAB, CRYBB2 
Molecular 
Function 
GO:0042802 Identical protein binding 
 HSPB1, CRYAB Cellular 
Component 
GO:0030018 Z disc 
CA1 ATP2A1, 
ATP2A2, PLN 
Biological 
Process 
GO:0048878 chemical homeostasis 
 ATP2A1, PLN Biological 
Process 
GO:0006937 regulation of muscle 
contraction 
  
 GO:0008016 regulation of heart 
contraction 
33 
 
 
Table 3.8 
 
Associated diseases of genes with enriched GO terms. 
 
Cluster Gene Associated Disease  
AA1 HSPB1 Axonal Charcot-Marie-Tooth disease type 2F 
and   Distal hereditary motor neuronopathy type 2B 
AA4 CRYAA Multiple types of cataract 9 
 CRYAB Multiple types of cataract 16 
  Dilated cardiomyopathy-1II 
  Myofibrillar myopathy-2 
  CRYAB-related fatal infantile hypertonic myofibrillar myopathy 
 CRYBB2 Multiple types of Cataract 3 
CA1 ATP2A1 Brody myopathy 
 ATP2A2 Acrokeratosis verruciformis 
  Darier disease 
 PLN Dilated cardiomyopathy-1P 
  Familial hypertrophic cardiomyopathy-18 
 
 
3.4.1 Duplication of HSPB1 and Health Disparities in African Americans 
Gene HSPB1 is located in genomic duplication regions occurring more frequently 
in African Americans (Table 3.6), and is found in the cluster family of AA1, AA2, AA3, 
and AA4 (Table 3.5). For cluster AA1, only one GO molecular function term related to 
gene HSPB1 is significantly enriched (Cluster AA1 in Table 3.7). For cluster AA4, in 
addition to the same enriched GO molecular functions term, three more GO biological 
process terms and one GO cellular component term are found significantly enriched 
(Cluster AA4 in Table 3.7). In the genes with the enriched GO terms, four of them are 
known to be associated with diseases (Cluster AA1/AA4 in Table 3.8). Among these four 
genes, three of them are implicated in health disparities of African Americans. 
Specifically, gene CRYAB is related to dilated cardiomyopathy and myofibrillar 
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myopathy. African Americans were found at higher risk for idiopathic dilated 
cardiomyopathy compared with Caucasian, and this could not be explained by income, 
education, alcohol use, smoking, or history of some other diseases (Coughlin et al. 1993). 
Moreover, gene CRYAA, CRYAB and CRYBB2 are all related to various types of cataract. 
It was reported that age-specific blindness prevalence was higher for African Americans 
compared with Caucasian, and cataract accounts for 36.8% of all blindness in African 
American, but for only 8.7% in Caucasian (Congdon et al. 2004).  
We would like to emphasize that gene HSPB1 is located in three CNVs that occur 
frequently in African Americans. Our results predict that HSPB1 is a potential causal 
gene in these CNVs for health disparities. How could HSPB1 duplication contribute to 
health disparity? Based on the direct interaction between HSPB1 and CRYAB and the fact 
that both genes are expressed in Z-disc (Table 3.7), it is plausible that HSPB1 may play 
an unknown role in cardiomyopathy. Alternatively, HSPB1 might be involved in cataract, 
because HSPB1, CRYAA and CRYAB interact with each other and all can negatively 
regulate apoptotic process (Table 3.7). Studies suggested that lens epithelial cell 
apoptosis may be a common cellular basis for initiation of non-congenital cataract 
formation (Li et al. 1995), and inhibition of epithelial cell apoptosis may be one possible 
mechanism that inhibits cataract development (Nahomi et al. 2013). Our results here 
argue for further experimental studies to test the possible role of HSPB1 CNVs in 
cardiomyopathy or cataract/blindness in African Americans.  
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3.4.2 Duplication of ATP2A1 and Health Disparities in Caucasians 
Gene ATP2A1 in cluster CA1 is located in a genomic duplication region that 
occurs only in Caucasians (Table 3.6). We found that three genes in cluster CA1 are 
enriched with various GO biological process terms that involve ATP2A1 (Cluster CA1 in 
Table 3.7). All of the three genes are related to diseases when they mutated (Cluster CA1 
in Table 3.8). Our results here predict that APT2A1 is a candidate causal gene for health 
disparity in this region.  
How would ATP2A1 influence health disparity? Among the diseases related to the 
pathogenic genes in cluster CA1, idiopathic dilated cardiomyopathy occurs less often in 
Caucasians than in African Americans (Coughlin et al. 1993). One possibility is that 
higher copies of ATP2A1 may offer some benefits to Caucasians. Studies have shown that 
increased activity of sarco/endoplasmic reticulum Ca2+-ATPase 1 (SERCA1), which is 
encoded by ATP2A1, can partially rescue the heart from •OH-induced injury 
(Hiranandani et al. 2006), and protect the heart from ischemia-reperfusion (I/R) injury 
(Talukder et al. 2007). Another possibility is that higher copies of ATP2A1 only lead to 
moderate risk of cardiomyopathy in Caucasians, and this moderate effect is 
overshadowed by other genetics factors not covered by our CNV dataset.  
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CHAPTER IV 
 
CONCLUSION 
 
 
In this study, we proposed a network clustering based approach to associate 
CNVs to health disparities in African and American. Gene clusters were inferred from 
two human gene/protein networks, HPRDNet and MultiNet, by MCL clustering 
algorithm with different parameters. Each cluster was ranked based on products of FDR 
values obtained from the right-tailed Fisher’s exact tests for enrichment of pathogenic 
genes or CNV-genes. Five clusters were consistently found to be ranked at first place and 
be enriched with both pathogenic genes and genes located in African-American or 
Caucasian CNVs. In cluster AA1, AA2, AA3 and AA4, gene HSPB1 is located in 
African-American-specific CNVs that are duplicated more frequently in African-
Americans. In clusters CA1, gene ATP2A1 is located in a Caucasian-specific CNV that is 
duplicated only in Caucasians. All gene clusters are associated with certain diseases that 
occur more often in one population than in the other, which could be considered as results 
of the occurrence of corresponding CNVs. Although we only studied population-
differential CNVs and did not consider the roles of other genetic factors, our 
computational studies have generated some interesting hypotheses for further 
experimental studies to understand health disparities in these diseases.  
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// Setup connection to UCSC Genome Database 
String username = "genome"; 
String password = ""; 
String url = "jdbc:mysql://genome-mysql.cse.ucsc.edu/hg19"; 
Class.forName("com.mysql.jdbc.Driver"); 
Connection con = DriverManager.getConnection(url, username, password); 
Statement stmt = con.createStatement(); 
ResultSet rs = null; 
 
// Search for gene names by SNP id  
// Compose and submit SQL statements to UCSC Genome Database  
rs = stmt.executeQuery( 
"select distinct S.name, X.geneSymbol " + 
"from snp138 as S, knownGene as G, kgXref as X " + 
"where S.name = '" + "rs" + new_snp + "' AND X.kgId = G.name AND  
S.chrom = G.chrom AND " + "G.txStart <= S.chromStart AND   
G.txEnd >= S.chromEnd;"); 
 
// extract results and write to output file 
if (rs.next()){ 
do { 
for (int i=1; i<3; i++) { output.print(rs.getString(i)+"\t"); } 
output.println(); 
}while (rs.next()); 
} 
else { output.println("rs" + new_snp + "\t" + "gene_not_found"); } 
 
// Search for gene names by CNV loci  
// Compose and submit SQL statements to UCSC Genome Database  
rs = stmt.executeQuery( 
"select distinct X.geneSymbol, G.chrom, G.txStart, G.txEnd " + 
"from knownGene as G, kgXref as X " + 
"where ((G.txStart>" + begin + " AND G.txEND<"   + end + ") or " + 
       "(G.txStart>" + begin + " AND G.txStart<" + end + ") or " + 
"(G.txEND>"   + begin + " AND G.txEND<"   + end + ") or " + 
       "(G.txStart<" + begin + " AND G.txEnd>"   + end + ")) AND " + 
       "X.kgId = G.name AND G.chrom = '" + chrom + "';"); 
 
// extract results and write to output file 
if (rs.next()) { 
do { 
  for (int l=1; l<5; l++) { output.print(rs.getString(l)+"\t"); } 
output.println(); 
}while (rs.next()); 
} 
else { output.println("not found"); } 
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//setup R engine 
Rengine re = new Rengine (new String[] {}, false, null); 
// Check if the session is working. 
if (!re.waitForR()) { return; } 
 
//Fisher's exact test for OMIM genes 
for (int k=1; k<=nCluster; k++) 
{ 
if(AA_GeneClusters[k].get_q() != 0) 
{ 
// obtain values and create the contingency table   
double cluster_q = AA_GeneClusters[k].get_q(); 
double cluster_m = AA_GeneClusters[k].get_m(); 
double cluster_nonOMIM = cluster_m - cluster_q; 
double other_OMIM = Q - cluster_q; 
double other_nonOMIM = N - Q - cluster_nonOMIM; 
re.eval("cluster = c("+cluster_q+","+cluster_nonOMIM+")"); 
re.eval("other = c("+other_OMIM+","+other_nonOMIM+")"); 
re.eval("tb = rbind(cluster, other)"); 
 
// perform the Fisher’s exact test and obtain the p-value 
double p_OMIM = re.eval("fisher.test(tb,  
 alternative=\"greater\")$p.value").asDouble(); 
} 
} 
 
//Fisher’s exact test for AA and CA genes 
for (int k=1; k<=nCluster; k++) 
{ 
double cluster_AA_s = AA_GeneClusters[k].get_s(); 
double cluster_CA_s = CA_GeneClusters[k].get_s(); 
double cluster_m = AA_GeneClusters[k].get_m();  
double other_AA = S_AA - cluster_AA_s; 
double other_CA = S_CA - cluster_CA_s; 
 
// Fisher's exact test for AA only 
if(AA_GeneClusters[k].get_s() != 0) 
{ 
// obtain values and create the contingency table   
double cluster_nonAA = cluster_m - cluster_AA_s; 
double other_nonAA = N-cluster_m-S_AA+cluster_AA_s; 
re.eval("cluster = c("+cluster_AA_s+","+cluster_nonAA+")"); 
re.eval("other = c("+other_AA+","+other_nonAA+")"); 
re.eval("tb = rbind(cluster, other)"); 
 
// perform the Fisher’s exact test and obtain the p-value 
double p_AA = re.eval("fisher.test(tb,  
 alternative=\"greater\")$p.value").asDouble(); 
} 
 
 // Fisher's exact test for CA only     
if(CA_GeneClusters[k].get_s() != 0) 
{ 
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// obtain values and create the contingency table   
double cluster_nonCA = cluster_m - cluster_CA_s; 
double other_nonCA = N-cluster_m-S_CA+cluster_CA_s; 
re.eval("cluster = c("+cluster_CA_s+","+cluster_nonCA+")"); 
re.eval("other = c("+other_CA+","+other_nonCA+")"); 
re.eval("tb = rbind(cluster, other)"); 
 
// perform the Fisher’s exact test and obtain the p-value 
double p_CA = re.eval("fisher.test(tb,  
 alternative=\"greater\")$p.value").asDouble(); 
} 
} 
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// Calculate FDR values   
//fp is the File object of input file 
Scanner pScan = new Scanner(fp); 
 
//RstatementA contains a R statement to create a tuple of all p-values. 
String RstatementA = "p=c("; 
while (pScan.hasNextLine()) 
{ 
String line = pScan.nextLine(); 
Scanner lineReader = new Scanner(line); 
lineReader.next(); 
int tmp = (int) lineReader.nextDouble(); 
if (tmp != 0) 
{ 
lineReader.next(); 
double p = lineReader.nextDouble(); 
RstatementA = RstatementA + p + ", "; 
log.println("RstatementA"+RstatementA); 
} 
} 
RstatementA = RstatementA.substring(0, RstatementA.length()-2) + ")"; 
 
// create a tuple named “p” 
re.eval(RstatementA); 
 
// load robust-fdr routine 
re.eval("source(\"D:/eclipse/workspace/test/robust-fdr.R\")"); 
 
// RstatementD contains a R statement to run robust-fdr routine 
String RstatementD = "robust.fdr(p, discrete=T, use8=F)$fdr"; 
 
// Obtain fdr values and save to an array 
double[] fdr_disc = re.eval(RstatementD).asDoubleArray(); 
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